About Saman Daroo
The Story of Saman Daroo 8
More than a decade ago, research on the production of recombinant human factor VIII was initiated by a group of leading academic researchers. After several years of research, in November 2008, Saman Daroo 8 Company was established with the mission of producing APIs and undertook the project. With appropriate investment, the project progressed from the laboratory phase to semi-industrial production at the Tehran University School of Pharmacy’s growth center. After completing clinical trials and obtaining the license, by the end of 2015, recombinant human factor VIII (rFVIII) branded as SAFACTO AF, was introduced to the market and made available to patients in need. Since 2010, construction of the industrial production site at the Khorasan Razavi Science and Technology Park in Mashhad began. This facility was ready for operation by the end of 2016 and is capable of producing a variety of biotechnology products.
Saman Daroo 8 Relying on its scientific strength, specialized expertise, and the unwavering commitment of its human capital, Saman Daroo 8 has outlined a clear and promising vision for the year 2030. With the goal of strengthening its position in Iran's biotechnology industry, the company aims to effectively harness modern technologies and focus on the therapeutic needs of patients with rare and complex diseases. While upholding its social and environmental responsibilities, Saman Daroo 8 aspires to rank among the top three companies in this field in terms of product quality and diversity.
Perspective for 2030
By 2030, Samandarooo 8 aims to become one of the top three biotechnology domain companies in Iran in terms of quality and production diversity, which is achieved through taking the advantage of technology, relying on competent expert human values, considering the needs of key stakeholders, and endeavoring to fulfill its social and environmental responsibilities.
Mission for the Year 2030
Our mission is to develop and produce advanced, innovative, and affordable biopharmaceuticals, focusing on treating rare diseases so as to firstly, meet national healthcare demands and secondly, exports to regional foreign markets.
The philosophy of existence of Samandarooo 8
At Samandarooo 8, we do believe that our commitment goes beyond drug manufacturing. We are dedicated to pave the way for improving the quality of lives of the patients suffering from rare diseases, and to strive to bring new hope for a healthier future with every achievement.
Fundamental values in the strategic plan (2026–2030)
– Health-Centered Approach : We believe health is a fundamental human right. Hence, our efforts are devoted to enhancing it.
– Purpose-Driven Innovation : We leverage science and technology to drive innovation that leads to effective and accessible treatments for the patients suffering from rare diseases.
– Quality and efficacy : We are committed to producing drugs that meet the highest scientific, quality, and clinical standards.
– Patient Commitment : Patients are the center of all our decisions and actions. We endeavor to improve their quality of life.
– National and Regional Development : We take responsible steps to meet the healthcare needs of our country, while we have a sustainable development-oriented attitude toward regional markets.
– Human values and Expertise : We do believe in our specialized workforce as the driving force of the organization emphasizing on constant learning and development.
– Social and Environmental Responsibility : We are aware of our responsibility towards society, the environment, and future generations. Therefore, we operate as per sustainable development principles.
– protecting and promoting the rights of key Stakeholder : We are fully committed to respecting and advancing the rights of our key stakeholders, ensuring permanent transparency and responsiveness.